The tumor immune microenvironment has been suggested to be closely associated with the biological behaviors of malignancies20 and participates in the phenotype classification of cancer immunotherapy.21 Tumor-infiltrating lymphocytes (TILs) and the expression of PD-L1 are critical factors for discriminating the different subtypes of the TIME and the response to ICI treatment. Here, CD274 is linked to neoplasm.